Comparison of a Reformulated Automated Vitamin D Assay, Its Predecessor, and 2 Contemporary Formulations
The Journal of Applied Laboratory Medicine · 2026
DOI: 10.1093/jalm/jfaf196 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, 2026. Verfasst von K Aaron Geno und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Dartmouth Health, Lebanon, NH, United States. Hauptthemen laut MEDLINE: Vitamin D, 25-Hydroxyvitamin D 2, Calcifediol, Vitamin D Deficiency. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Historically, 25-hydroxyvitamin D (25OHD) assays have under- or over-recovered 25-hydroxyvitamin D2 (25OHD2), but assay manufacturers have modified their reagents to address this problem. In this study, we compared the second- and third-generation Roche assays as well as two contemporary offerings from Diasorin and Beckman against liquid chromatography–tandem mass spectrometry (LC-MS/MS).
Methods
We identified 50 remnant serum samples with 25OHD concentrations from across the analytical range of the second-generation Roche assay. To increase 25OHD2 representation, we identified 25 additional samples from individuals prescribed high-dose vitamin D2 supplements. We tested samples on Roche assays and circulated to laboratories performing Beckman and Diasorin 25OHD assays. We tested samples by LC-MS/MS to obtain concentrations for 25OHD2 and 25-hydroxyvitamin D3.
Results
Mean overall bias for each assay was 5.1 ng/mL or less against the LC-MS/MS measurement; mean proportional bias was 8.7% to 12.1%. Some individual specimens had much larger bias. 25OHD2 was under-recovered on average, but the bias for the third-generation Roche assay represents a significant improvement over the previous assay, and mean bias for current generation assays was no worse than −3.2 ng/mL. In most cases, clinical classification by automated assay values agreed with clinical classification by LC-MS/MS; where present, disagreements occurred near classification thresholds.
Conclusions
Automated 25OHD assays continue to improve, and 25OHD2 recovery no longer appears to be a significant concern for the assays evaluated here. All assays evaluated were adequate for clinical classification of vitamin D nutritional status and are suitable for routine use, including in patients prescribed high-dose vitamin D2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Dartmouth Health, Lebanon, NH, United States.
- Geisel School of Medicine at Dartmouth, Hanover, NH, United States.
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
- Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI, United States.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
ORCID-Profile: K Aaron Geno, Robert D Nerenz
Zitieren
APA
Geno, K. A., Alvarez, Y. F., Hubbard, J. A., Nerenz, R. D., & Singh, R. J. (2026). Comparison of a Reformulated Automated Vitamin D Assay, Its Predecessor, and 2 Contemporary Formulations. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfaf196
Vancouver
Geno KA, Alvarez YF, Hubbard JA, Nerenz RD, Singh RJ. Comparison of a Reformulated Automated Vitamin D Assay, Its Predecessor, and 2 Contemporary Formulations. The Journal of Applied Laboratory Medicine. 2026. doi:10.1093/jalm/jfaf196
BibTeX
@article{Geno2026,
author = {Geno, K Aaron and Alvarez, Yasel F and Hubbard, Jacqueline A and Nerenz, Robert D and Singh, Ravinder J},
title = {Comparison of a Reformulated Automated Vitamin D Assay, Its Predecessor, and 2 Contemporary Formulations},
journal = {The Journal of Applied Laboratory Medicine},
year = {2026},
doi = {10.1093/jalm/jfaf196}
}
EUVIMED